‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Measles Deaths Rose To 140,000 In 2018; DRC Cases Account For One-Third Of 2019 Infections 05/12/2019 Grace Ren Measles deaths are on the rise for the second year in a row, killing more than 140,000 people worldwide in 2018 according to estimates released Thursday by the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). Also on Thursday, a massive measles vaccination campaign was announced in North Kivu, […] Continue reading -> Posts navigation Older postsNewer posts